Nwam LLC Horizon Therapeutics Public LTD CO Transaction History

Nwam LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 12, 2023	SELL	$107.32 - $113.5 $14,702 - $15,549	-137 Reduced 6.25%	2,054 $224,000
Q4 2022 Feb 07, 2023	BUY	$62.39 - $113.8 $136,696 - $249,335	2,191 New	2,191 $249,000
Q2 2022 Aug 10, 2022	SELL	$79.4 - $116.36 $160,308 - $234,930	-2,019 Closed	0 $0
Q1 2022 May 12, 2022	SELL	$86.42 - $109.81 $18,321 - $23,279	-212 Reduced 9.5%	2,019 $212,000
Q4 2021 Feb 10, 2022	BUY	$98.56 - $119.91 $2,562 - $3,117	26 Added 1.18%	2,231 $240,000
Q3 2021 Nov 03, 2021	BUY	$91.91 - $110.37 $275 - $331	3 Added 0.14%	2,205 $242,000
Q2 2021 Aug 04, 2021	BUY	$86.24 - $95.92 $189,900 - $211,215	2,202 New	2,202 $206,000

2.07M

20K

Ticker HZNP
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 230,384,000
Description
Horizon Therapeutics Public Limited Company, a biotechnology company, focuses on the discovery, development, and commercialization of medicines that address critical needs for people impacted by rare, autoimmune, and severe inflammatory diseases. The company operates in two segments, Orphan and Inflammation. Its portfolio comprises 12 medicines ...

Get notified when there are updates to the investment portfolio of Nwam LLC, based on Form 13F filings with the SEC.

Stay updated on Nwam LLC with notifications on news.